Barak UpdatesHappeningsBreaking News

Covid vaccines to be administered at 6 centres in Silchar on 18 Dec

Dec. 17:  Dr Reema Patao, Medical Officer of Urban Family Welfare Unit, Silchar on Friday stated that on-spot vaccination session will take place at 5 centres in Silchar on Saturday where Covishield will be administered, whereas Covaxin will be provided at 01 centre. A total of 1,200 doses of Covishield and 100 doses of Covaxin will be administered on 18 December in Silchar town.

The 5 vaccination centres where Covishield will be provided are:

  • SM Dev Civil Hospital, Silchar: Both 1st dose (100 shots) and 2nd dose (200 shots) will be given on the basis of on-spot registration. That means, a total of 300 doses of Covishield will be administered in this centre on 18 December.
  • Sanjibini (104) office, Opposite Urban PHC, Trunk Road: Both 1st dose (100 shots) and 2nd dose (200 shots) will be given on the basis of on-spot registration. That means, a total of 300 doses of Covishield will be administered in this centre on 18 December.
  • Durga ShankarPatshala: Both 1st dose (100 shots) and 2nd dose (100 shots) will be given on the basis of on-spot registration. That means, a total of 200 doses of Covishield will be administered in this centre on 18 December.
  • Abhaya Charan Patshala: Both 1st dose (100 shots) and 2nd dose (100 shots) will be given on the basis of on-spot registration. That means, a total of 200 doses of Covishield will be administered in this centre on 18 December.
  • BC Roy School, Rongpur: Both 1st dose (100 shots) and 2nd dose (100 shots) will be given on the basis of on-spot registration. That means, a total of 200 doses of Covishield will be administered in this centre on 18 December.

The vaccination centre where Covaxin will be provided is:

  • Sanjibini (104) office, Opposite Urban PHC, Trunk Road: Both 1st dose (50 shots) and 2nd dose (50 shots) will be given on the basis of on-spot registration on 18 December.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

error: Content is protected !!
Close
Close

Adblock Detected

Please consider supporting us by disabling your ad blocker